Keyphrases
Rare Variants
100%
Type 2 Diabetes Risk
100%
Decreased Activity
100%
Peroxisome Proliferator-activated Receptor
100%
Adipocyte Differentiation
100%
Type 2 Diabetes Mellitus (T2DM)
28%
Gain-of-function mutation
28%
Differentiation Assay
28%
Human Adipocytes
28%
Insulin Resistance
14%
Ethnic Groups
14%
Functional Consequences
14%
Reducing Activity
14%
DNA Sequencing
14%
Decreased Risk
14%
High-throughput
14%
Increasing Risk
14%
Lipodystrophy
14%
Antidiabetic
14%
Transcriptional Regulator
14%
Functional Testing
14%
Computational Prediction
14%
Nonsynonymous
14%
Family Loss
14%
Canonical Targets
14%
Thiazolidinediones
14%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
100%
Adipocyte
100%
Peroxisome Proliferator Activated Receptor Gamma
100%
Population
28%
Insulin Resistance
14%
Drug Therapy
14%
Ethnic Group
14%
DNA Sequence
14%
Loss of Function Mutation
14%
Glitazone Derivative
14%
Lipodystrophy
14%
Biochemistry, Genetics and Molecular Biology
Adipocyte
100%
Peroxisome Proliferator-Activated Receptor Gamma
100%
Population
28%
Insulin Resistance
14%
DNA Sequence
14%
Loss of Function Mutation
14%
Thiazolidinedione
14%
Immunology and Microbiology
Peroxisome
100%
Adipocyte
100%
Population
28%
DNA Sequence
14%
Loss of Function Mutation
14%
Insulin Resistance
14%
Pharmacology, Toxicology and Pharmaceutical Science
Non Insulin Dependent Diabetes Mellitus
100%
Peroxisome Proliferator Activated Receptor Gamma
100%
Insulin Resistance
14%
Lipodystrophy
14%
Glitazone Derivative
14%